current clinical evidence shows no mechanism for cardiac atrophy and suggests potential cardiovascular benefits instead
In a yearlong Phase 3 trial, the highest dose of Lilys pill, orforglipron, lowered a measure of blood sugar called A1C by 1.9 percentage points, while the highest dose of Novos drug, marketed as Rybelsus, lowered A1C by 1.5 percentage points, when analyzing all patients regardless of discontinuations
Importantly, these medications carry a boxed warning for risk of thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), and are contraindicated in patients with personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2
In a clinical trial with nearly 1,000 participants, people on resmetirom were more likely to see improvement in their condition than those taking a placebo, researchers reported in the New England Journal of Medicine
Ferritinophagy is involved in the zinc oxide nanoparticles-induced ferroptosis of vascular endothelial cells
K.PatelP